106 related articles for article (PubMed ID: 9506867)
1. The endogenous feeding suppressant, 2-buten-4-olide, impairs the pulsatile secretion of luteinizing hormone through endogenous opioid peptides.
Kaji H; Saito S; Shitsukawa K; Irahara M; Aono T
Eur J Endocrinol; 1998 Feb; 138(2):198-205. PubMed ID: 9506867
[TBL] [Abstract][Full Text] [Related]
2. Effects of 2-buten-4-olide, an endogenous feeding suppressant, on the pulsatile secretion of luteinizing hormone in ovariectomized rats.
Saito S; Shitsukawa K; Irahara M; Matsuzaki T; Aono T
Acta Endocrinol (Copenh); 1993 Nov; 129(5):467-72. PubMed ID: 8279227
[TBL] [Abstract][Full Text] [Related]
3. Induction of Fos-like immunoreactivity in the rat hypothalamus by an endogenous feeding suppressant (2-buten-4-olide).
Hisano S; Uemura N; Fukui Y; Miki M; Zhang R
Neurosci Lett; 1994 Nov; 182(1):80-2. PubMed ID: 7891895
[TBL] [Abstract][Full Text] [Related]
4. Hypothalamic Ghrelin suppresses pulsatile secretion of luteinizing hormone via beta-endorphin in ovariectomized rats.
Ogata R; Matsuzaki T; Iwasa T; Kiyokawa M; Tanaka N; Kuwahara A; Yasui T; Irahara M
Neuroendocrinology; 2009; 90(4):364-70. PubMed ID: 19907132
[TBL] [Abstract][Full Text] [Related]
5. 2-Buten-4-Olide (2-B4O) suppresses feeding in neonate and developing rat pups.
Mathur R
Physiol Behav; 2010 Sep; 101(2):232-6. PubMed ID: 20493892
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical localization of beta endorphin and gonadal steroid regulation of proopiomelanocortin messenger ribonucleic acid in the ewe.
Whisnant CS; Curto K; Goodman RL
Neuroendocrinology; 1992 Dec; 56(6):812-21. PubMed ID: 1369589
[TBL] [Abstract][Full Text] [Related]
7. Effects of the short chain sugar acid 2-buten-4-olide on the hypothalamo-pituitary-adrenal axis in normal and adjuvant-induced arthritic rats.
Kawasaki M; Onaka T; Saito J; Hashimoto H; Suzuki H; Otsubo H; Fujihara H; Okimoto N; Ohnishi H; Nakamura T; Ueta Y
J Neuroendocrinol; 2007 Jan; 19(1):54-65. PubMed ID: 17184486
[TBL] [Abstract][Full Text] [Related]
8. Effect of 2-buten-4-olide, an endogenous suppressant of feeding, on reproductive function in rats.
Shitsukawa K; Irahara M; Kanematsu T; Azuma K; Aono T
Acta Endocrinol (Copenh); 1990 Nov; 123(5):571-6. PubMed ID: 2256437
[TBL] [Abstract][Full Text] [Related]
9. Effect of an endogenous satiety substance, 2-buten-4-olide, on gastric acid secretion and experimental ulceration in rats.
Arai I; Usuki-Ito C; Muramatsu M; Otomo S; Shiraishi T; Oomura Y
Physiol Behav; 1990 Jan; 47(1):197-202. PubMed ID: 2326336
[TBL] [Abstract][Full Text] [Related]
10. Endogenous opioid regulation of pulsatile luteinizing hormone secretion during sexual maturation in the female sheep.
Ebling FJ; Schwartz ML; Foster DL
Endocrinology; 1989 Jul; 125(1):369-83. PubMed ID: 2737153
[TBL] [Abstract][Full Text] [Related]
11. Melatonin inhibits naloxone-induced luteinizing hormone release in ovariectomized estrogen-primed rats.
Akema T; Chiba A; Ikeda T; Nagami Y; Kimura F; Toyoda J
J Neuroendocrinol; 1997 Nov; 9(11):849-57. PubMed ID: 9419836
[TBL] [Abstract][Full Text] [Related]
12. Physiological significance of 2-buten-4-olide (2-B4O), an endogenous satiety substance increased in the fasted state.
Oomura Y; Aou S; Matsumoto I; Sakata T
Exp Biol Med (Maywood); 2003 Nov; 228(10):1146-55. PubMed ID: 14610253
[TBL] [Abstract][Full Text] [Related]
13. 2-Buten-4-olide (2-B4O) inhibits type II collagen-induced arthritis in Lewis rats.
Takeoka Y; Naiki M; Taguchi N; Imai H; Kurimoto Y; Morita S; Suehiro S
Int J Immunopharmacol; 1993 Oct; 15(7):803-10. PubMed ID: 8262694
[TBL] [Abstract][Full Text] [Related]
14. Participation of both adrenergic and opioidergic systems in the negative feedback of adrenal progesterone on LH secretion.
Salicioni AM; Carón RW; Deis RP
Eur J Pharmacol; 1997 Aug; 332(3):283-7. PubMed ID: 9300262
[TBL] [Abstract][Full Text] [Related]
15. Nocturnal naloxone fails to reverse the suppressive effects of testosterone infusion on luteinizing hormone secretion in pubertal boys.
Kletter GB; Foster CM; Brown MB; Beitins IZ; Marshall JC; Kelch RP
J Clin Endocrinol Metab; 1994 Oct; 79(4):1147-51. PubMed ID: 7962287
[TBL] [Abstract][Full Text] [Related]
16. Disinhibition from opioid influence augments hypothalamic neuropeptide Y (NPY) gene expression and pituitary luteinizing hormone release: effects of NPY messenger ribonucleic acid antisense oligodeoxynucleotides.
Xu B; Sahu A; Kalra PS; Crowley WR; Kalra SP
Endocrinology; 1996 Jan; 137(1):78-84. PubMed ID: 8536645
[TBL] [Abstract][Full Text] [Related]
17. Region-related Fos expression in hypothalamic dopaminergic neurons of rats by intraperitoneal administration of an endogenous satiety substance, 2-buten-4-olide.
Hisano S; Zhang R; Uemura N; Fukui Y; Miki T
Brain Res; 1995 Apr; 676(2):409-12. PubMed ID: 7614014
[TBL] [Abstract][Full Text] [Related]
18. Reduced frequency of pulsatile luteinizing hormone secretion in the luteal phase of the rhesus monkey. Involvement of endogenous opiates.
Van Vugt DA; Lam NY; Ferin M
Endocrinology; 1984 Sep; 115(3):1095-101. PubMed ID: 6745188
[TBL] [Abstract][Full Text] [Related]
19. Suppression of pulsatile luteinizing hormone secretion but not luteinizing hormone surge in leptin resistant obese Zucker rats.
Todd BJ; Ladyman SR; Grattan DR
J Neuroendocrinol; 2003 Jan; 15(1):61-8. PubMed ID: 12535170
[TBL] [Abstract][Full Text] [Related]
20. Endogenous opioid peptide regulation of pulsatile luteinizing hormone secretion during pregnancy in the rat.
Devorshak-Harvey E; Bona-Gallo A; Gallo RV
Neuroendocrinology; 1987 Nov; 46(5):369-78. PubMed ID: 3323939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
